Published in Cancer Weekly, November 9th, 2004
Results from a series of studies by investigators at St. Jude Children's Research Hospital are published in a recent issue of Molecular and Cellular Biology (MCB).
The St. Jude team, which developed a mouse model lacking the Mrp4 protein, says study results in both mice and tissue cultures suggest that the therapeutic efficacy of drugs targeting central nervous system tumors might be improved by inhibiting this protein, a type of molecule called an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.